IMMU-16. INTRA-TUMOURAL IL-12 DELIVERY ENABLES CAR T-CELL IMMUNOTHERAPY FOR HIGH-GRADE GLIOMA

Treatment with T-cells redirected to tumour specificity with a chimeric antigen receptor (CAR) may be well suited to treat intracranial tumours due to the ability of T-cells to access the central nervous system and migrate to infiltrative sites of disease. In adult glioblastoma, a case report of loc...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Agliardi, Giulia, Liuzzi, Anna Rita, Hotblack, Alastair, De Feo, Donatella, Núñez, Nicolás, Friebel, Ekaterina, Nannini, Francesco, Roberts, Thomas, Ramasawmy, Rajiv, Stowe, Cassandra, Williams, Iwan, Siow, Bernard, Lythgoe, Mark, Kalber, Tammy, Quezada, Sergio, Pule, Martin, Tugues, Sonia, Becher, Burkhard, Straathof, Karin
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Immunotherapy
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7715834/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa222.372
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados